Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

InControl Medical obtains FDA approval for InToneMV device

US-based InControl Medical has obtained an approval from the US Food and Drug Administration (FDA) for its InToneMV device, which provides both men and women a non-surgical treatment option for urinary and fecal incontinence.

Developed by the makers of InTone, InToneMV is a smaller, comfortable medical device that treats stress, urge and mixed incontinence for men and those women who suffer with vaginal atrophy.

InTone is listed as a Class II medical device by the FDA for the treatment of female urinary incontinence.

InControl Medical founder and CEO Herschel Peddicord noted "While InTone has helped countless women solve the embarrassing and uncomfortable issue of involuntary loss of urine, InToneMV allows us to expand our product line to help both men and women suffering with urinary and fecal incontinence."

For creating a home-based treatment for incontinence, the InTone and InToneMV devices combine muscle stimulation with voice-guided pelvic floor exercise, visual biofeedback, and a customizable probe.

This comprehensive approach provides users with an easy-to-use program without surgery, diapers, pads or meds, InControl Medical claims.